文献速递临床试验与 GCP

无引流管机器人辅助微创食管切除术随机对照试验(RESPECT)

Drainless robot-assisted minimally invasive oesophagectomy-randomized controlled trial (RESPECT).
PubMed 文献 · Trials · 2023-05-02

这是一项多中心随机对照试验,计划纳入72例接受机器人辅助微创食管切除术(RAMIE)的患者,干预组36例在无禁忌证时于术后3小时拔除腹腔和胸腔引流管,对照组36例按标准流程管理引流管。主要终点为术后第二天NRS疼痛评分,次要终点包括第一周疼痛强度、镇痛药使用、术后胸部X线和CT扫描次数、干预措施、术后活动度、并发症和死亡率。

要点

  • 评价RAMIE术后早期拔除引流管的可行性与疼痛、康复及并发症情况。
  • 干预组术后3小时拔除腹腔和胸腔引流管,对照组按标准流程拔除。
  • 主要终点为术后第二天NRS疼痛评分,计划样本量72例。

核心结论

  • 该随机对照试验将提供无引流管RAMIE有效性和可行性的统计学证据。

研究设计与样本

  • 随机对照多中心试验,计划纳入72例接受RAMIE的患者,干预组36例,对照组36例。

主要发现

  • 干预组在无禁忌证时于手术结束后3小时拔除腹腔和胸腔引流管。
  • 对照组按标准算法在术后进一步病程中拔除胸腔引流管。
  • 主要终点为术后第二天NRS疼痛评分是否在干预组显著降低。
  • 次要终点包括第一周疼痛强度、镇痛药使用、术后胸部X线和CT扫描次数、干预措施、术后活动度(活动追踪器每日步数)、术后并发症和死亡率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this randomized trial is to evaluate the early removal of postoperative drains after robot-assisted minimally invasive oesophagectomy (RAMIE). Evidence is lacking about feasibility, associated pain, recovery, and morbidity. METHODS/DESIGN: This is a randomized controlled multicentric trial involving 72 patients undergoing RAMIE. Patients will be allocated into two groups. The "intervention" group consists of 36 patients. In this group, abdominal and chest drains are removed 3 h after the end of surgery in the absence of contraindications. The control group consists of 36 patients with conventional chest drain management. These drains are removed during the further postoperative course according to a standard algorithm. The primary objective is to investigate whether postoperative pain measured by NRS on the second postoperative day can be significantly reduced in the intervention group. Secondary endpoints are the intensity of pain during the first week, analgesic use, number of postoperative chest X-ray and CT scans, interventions, postoperative mobilization (steps per day as measured with an activity tracker), postoperative morbidity and mortality. DISCUSSION: Until now, there have been no trials investigating different intraoperative chest drain strategies in patients undergoing RAMIE for oesophageal cancer with regard to perioperative complications until discharge. Minimally invasive approaches combined with enhanced recovery after surgery (ERAS) protocols lower morbidity but still include the insertion of chest drains. Reduction and early removal have been proposed after pulmonary surgery but not after RAMIE. The study concept is based on our own experience and the promising current results of the RAMIE procedure. Therefore, the presented randomized controlled trial will provide statistical evidence of the effectiveness and feasibility of the "drainless" RAMIE. TRIAL REGISTRATION: ClinicalTrials.gov NCT05553795. Registered on 23 September 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Müssle B, Kirchberg J, Buck N, et al. Drainless robot-assisted minimally invasive oesophagectomy-randomized controlled trial (RESPECT). Trials. 2023. PMID: 37127683. doi:10.1186/s13063-023-07233-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。